| 5.415 -0.015 (-0.28%) | 12-15 15:40 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 11.64 |
1-year : | 15.47 |
| Resists | First : | 9.97 |
Second : | 13.25 |
| Pivot price | 6.14 |
|||
| Supports | First : | 4.66 |
Second : | 3.88 |
| MAs | MA(5) : | 6.5 |
MA(20) : | 6.02 |
| MA(100) : | 9.38 |
MA(250) : | 0 | |
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 6 |
D(3) : | 22.9 |
| RSI | RSI(14): 45.5 |
|||
| 52-week | High : | 1444.5 | Low : | 4.66 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ ENVB ] has closed above bottom band by 33.7%. Bollinger Bands are 13.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 6.24 - 6.28 | 6.28 - 6.31 |
| Low: | 5.28 - 5.32 | 5.32 - 5.35 |
| Close: | 5.41 - 5.47 | 5.47 - 5.52 |
Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
Fri, 12 Dec 2025
Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds - Business Wire
Thu, 11 Dec 2025
Enveric Biosciences (ENVB) Modifies Warrant Terms to Raise Funds - GuruFocus
Wed, 10 Dec 2025
Enveric Biosciences Stock Poised for Growth? - StocksToTrade
Wed, 10 Dec 2025
Enveric Biosciences (ENVB) Stock Surges on Patent Win: News, Forecast & Analysis as of December 10, 2025 - ts2.tech
Tue, 09 Dec 2025
What Sparked Enveric Biosciences (ENVB) 74% Surge In After-Hours Trading? - Sahm
Tue, 09 Dec 2025
Enveric Biosciences (ENVB) Gains Patent Approval for EVM301 Ment - GuruFocus
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 1 (M) |
| Held by Insiders | 594390 (%) |
| Held by Institutions | 0.4 (%) |
| Shares Short | 30 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -133.3 % |
| Return on Equity (ttm) | -262.8 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -3.52222e+007 |
| Qtrly Earnings Growth | 390.6 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -8 (M) |
| PE Ratio | 5.38 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0.21 |
| Dividend | 0 |
| Forward Dividend | 43620 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|